Skip to content
OpenCapital
Get started

Anavex Life Sciences Corp. AVXL Q3 2025 Annual earnings

Reported November 25, 2025 · Before market open

Diluted EPS-$0.11Beat by $0.02
EPS estimate-$0.13

Next report

Jul 16, 2026 (In 4 days)
EPS estimate-$0.07

Versus estimates

Diluted EPS

Q1 2026-$0.07In lineQ4 2025-$0.06Beat by $0.04
Q3 2025-$0.11Beat by $0.02
Q2 2025-$0.16Miss by $0.03Q1 2025-$0.13Beat by $0.03Q4 2024-$0.14Beat by $0.03

Ask the moment Anavex Life Sciences Corp. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Anavex Life Sciences Corp. report Q3 2025 earnings?
Anavex Life Sciences Corp. (AVXL) reported Q3 2025 earnings on November 25, 2025 before market open.
What were Anavex Life Sciences Corp.'s Q3 2025 revenue and EPS?
Anavex Life Sciences Corp. reported diluted EPS of $-0.11 for Q3 2025.
Did Anavex Life Sciences Corp. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.13 by $0.02.
How did Anavex Life Sciences Corp.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 21.4% from $-0.14.
Where can I find Anavex Life Sciences Corp.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001731122-25-001591) and the 10-K periodic report (0001731122-25-001596) directly on SEC EDGAR. The filing index links above go to sec.gov.